Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Conditions: Hereditary Hemorrhagic Telangiectasia; Arteriovenous Malformations; Telangiectasia; Epistaxis; GastroIntestinal Bleeding; Cerebral Arteriovenous Malformations; Vascular Malformation Sponsors: Cure HHT; Augusta University; The Cleveland Clinic; Mayo Clinic; Massachusetts General Hospital; Columbia University; Oregon Health and Science University; University of California, Los Angeles; University of California, San Francisco; University of Colorado, Denver; University of North Carolina, Chapel Hill; University of Pennsylvania; University of Texas; University of Utah; Washington University School of Medicine; Yale University; Health Resources and Services Administration (HRSA) Recruiting

https://clinicaltrials.gov/study/NCT06259292

Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials